microdosing of glp 1 GLP-1s: Reduce Inflammation, Support Cognitive Health, and More — Dr. Michelle Weiner at NeuroPain Health GLP-1 Microdosing: A Slower, Smarter

Uptake for these two glucagon-like peptide receptor agonists (GLP-1 RAs) has surpassed expectations and is driving demand for Saxenda (liraglutide), an older GLP-1 also indicated for weight loss, along with off-label use of Ozempic (semaglutide) and Mounjaro (tirzepatide), two GLP-1 formulations indicated for treating diabetes

Many plans impose step therapy requirements, forcing patients to fail cheaper agents first before approving expensive GLP-1s

To accomplish sustainable weight loss, its essential to focus on long-term lifestyle habits to help maintain weight loss after stopping the medication

Increased glucagon-like peptide-1 secretion may be involved in antidiabetic effects of ginsenosides

Licensed providers determine which option is clinically appropriate based on your individual situation

Journal of diabetes science and technology 4 , 13221331 (2010)